Analyst firms · H.C. Wainwright · VTYX

H.C. Wainwright VTYX price target and rating history

Ventyx Biosciences Inc. (VTYX) · Health Care

H.C. Wainwright rates Ventyx Biosciences Inc. (VTYX) Buy with a $18 price target, as of its latest action on Nov 5, 2025. It has published 3 rating actions on VTYX since September 2022, including 1 upgrade and 1 downgrade.

Current rating
Buy
Price target
$18
Median target, all firms
Too few
Actions on VTYX
3

H.C. Wainwright price target on VTYX

$36$27$182023202420252026
H.C. Wainwright price target on VTYX, each point a stated target, September 2022 to November 2025.

Every H.C. Wainwright rating on VTYX

Questions about H.C. Wainwright and VTYX

What is H.C. Wainwright's price target for VTYX?
H.C. Wainwright's latest stated price target for Ventyx Biosciences Inc. (VTYX) is $18, from its action on Nov 5, 2025.
What is H.C. Wainwright's rating on VTYX?
H.C. Wainwright rates VTYX Buy, a bullish rating, as of Nov 5, 2025.
When did H.C. Wainwright last change its view on VTYX?
On Nov 5, 2025, H.C. Wainwright upgrades to Buy from Neutral, price target $18.

More VTYX rating histories

All H.C. Wainwright ratingsVTYX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.